Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Enanta Pharmaceutica (ENTA)

Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Enanta Pharmaceutica 4 KINGSBURY AVENUE WATERTOWN MA 02472 USA

www.enanta.com Employees: 120 P: 617-607-0800 F: 617-607-0530

Sector:

Medical

Description:

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 414,972
Enterprise Value, $K 383,982
Shares Outstanding, K 29,019
Float, K 25,688
% Float 88.52%
Short Interest, K 2,261
Short Float 7.79%
Days to Cover 10.23
Short Volume Ratio 0.60
% of Insider Shareholders 11.48%
% of Institutional Shareholders 94.99%

Financials:

Annual Sales, $ 65,320 K
Annual Net Income, $ -81,890 K
Last Quarter Sales, $ 18,620 K
Last Quarter Net Income, $ -11,940 K
EBIT, $ -73,060 K
EBITDA, $ -67,970 K

Growth:

1-Year Return 81.47%
3-Year Return -69.90%
5-Year Return -72.20%
5-Year Revenue Growth -46.66%
5-Year Earnings Growth -331.46%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.87 on 11/17/25
Next Earnings Date 05/11/26
Earnings Per Share ttm -3.20
EPS Growth vs. Prev Qtr 51.72%
EPS Growth vs. Prev Year 60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ENTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -78.59%
Return-on-Assets % -23.18%
Profit Margin % -125.37%
Debt/Equity 0.00
Price/Sales 6.35
Price/Cash Flow N/A
Price/Book 3.30
Book Value/Share 4.36
Interest Coverage -9.88
60-Month Beta 0.98
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar